---
questionId: 59
modelId: Alice
modelDisplayName: 匿名模型E
---
[药明康德](windlocal://open?!CommandParam\(1400%2CWindCode%3D603259.SH\)%27)2025年第二季度的财务数据显示其经营状况稳健，主要财务指标如下：

### 主要财务指标概览

表格复制

|指标|数值|
|---|---|
|**​[营业收入](windlocal://open?!CommandFunc\(ExecuteCmd\(CMDID%3D1601\)%3BAddSheet\(\)%3BSelectIndicator\(id%3D255842\)\)%27)​**|111.45 亿元|
|**​[净利润](windlocal://open?!CommandFunc\(ExecuteCmd\(CMDID%3D1601\)%3BAddSheet\(\)%3BSelectIndicator\(id%3D255871\)\)%27)​**|49.45 亿元|
|**​[每股收益](windlocal://open?!CommandFunc\(ExecuteCmd\(CMDID%3D1601\)%3BAddSheet\(\)%3BSelectIndicator\(id%3D601297\)\)%27) (EPS)​**|1.70 元|
|**​净资产收益率 (ROE)​**|8.00%|
|**​总资产净利率 (ROA)​**|5.88%|
|**​[营业总成本](windlocal://open?!CommandFunc\(ExecuteCmd\(CMDID%3D1601\)%3BAddSheet\(\)%3BSelectIndicator\(id%3D255846\)\)%27)​**|75.78 亿元|
|**​[销售费用](windlocal://open?!CommandFunc\(ExecuteCmd\(CMDID%3D1601\)%3BAddSheet\(\)%3BSelectIndicator\(id%3D255851\)\)%27)​**|2.00 亿元|
|**​[管理费用](windlocal://open?!CommandFunc\(ExecuteCmd\(CMDID%3D1601\)%3BAddSheet\(\)%3BSelectIndicator\(id%3D255852\)\)%27)​**|6.13 亿元|
|**​[财务费用](windlocal://open?!CommandFunc\(ExecuteCmd\(CMDID%3D1601\)%3BAddSheet\(\)%3BSelectIndicator\(id%3D255853\)\)%27)​**|1.35 亿元|

### 同比增长率

表格复制

|指标|增长率|
|---|---|
|**​营业收入同比增长率​**|20.37%|
|**​[净利润同比增长率](windlocal://open?!CommandFunc\(ExecuteCmd\(CMDID%3D1601\)%3BAddSheet\(\)%3BSelectIndicator\(id%3D600169\)\)%27)​**|112.96%|

药明康德在2025年第二季度实现了显著的[收入](windlocal://open?!CommandFunc\(ExecuteCmd\(CMDID%3D1601\)%3BAddSheet\(\)%3BSelectIndicator\(id%3D255841\)\)%27)和[利润](windlocal://open?!CommandFunc\(ExecuteCmd\(CMDID%3D1601\)%3BAddSheet\(\)%3BSelectIndicator\(id%3D255871\)\)%27)增长，尤其是[净利润](windlocal://open?!CommandFunc\(ExecuteCmd\(CMDID%3D1601\)%3BAddSheet\(\)%3BSelectIndicator\(id%3D84959\)\)%27)同比增幅超过110%，显示出公司在盈利能力方面的大幅提升。同时，[ROE](windlocal://open?!CommandFunc\(ExecuteCmd\(CMDID%3D1601\)%3BAddSheet\(\)%3BSelectIndicator\(id%3D84328\)\)%27)和[ROA](windlocal://open?!CommandFunc\(ExecuteCmd\(CMDID%3D1601\)%3BAddSheet\(\)%3BSelectIndicator\(id%3D84336\)\)%27)也分别达到8.00%和5.88%，表明公司资产和资本的利用效率较高。

如需进一步了解药明康德的财务详情，可参考Wind金融终端中提供的完整数据。请注意，以上信息基于Wind提供的数据，可能存在后续调整的风险，建议以公司正式公告为准。

以上数据仅为参考，**​不构成投资建议​**。